MD
De Kraker, Marlieke
Affiliation entities
Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
---|---|---|---|---|---|---|---|
Universal Risk Factors for Mortality in Bloodstream Infections (UNIFORM) : a systematic review and Delphi survey | Clinical microbiology and infection | 2024 | 11 | 0 | |||
The scope of the antimicrobial resistance challenge | Lancet | 2024 | 16 | 0 | |||
Risk factors for bloodstream infections due to carbapenem-resistant Enterobacterales : a nested case-control-control study | Journal of antimicrobial chemotherapy | 2024 | 18 | 8 | |||
Antimicrobial resistance in Enterobacterales infections among children in sub-Saharan Africa : a systematic review and meta-analysis | EClinicalMedicine | 2024 | 54 | 134 | |||
Attributable mortality of infections caused by carbapenem-resistant Enterobacterales : results from a prospective, multinational case-control-control matched cohorts study (EURECA) | Clinical microbiology and infection | 2024 | 15 | 20 | |||
Hospital Outcomes of Community-Acquired SARS-CoV-2 Omicron Variant Infection Compared With Influenza Infection in Switzerland | JAMA network open | 2023 | 72 | 22 | |||
Excess resource use and cost of drug-resistant infections for six key pathogens in Europe : a systematic review and Bayesian meta-analysis | Clinical microbiology and infection | 2023 | 57 | 19 | |||
Timing of Cefuroxime Surgical Antimicrobial Prophylaxis and Its Association With Surgical Site Infections | JAMA network open | 2023 | 58 | 18 | |||
Mortality associated with third-generation cephalosporin resistance in Enterobacterales bloodstream infections at eight sub-Saharan African hospitals (MBIRA) : a prospective cohort study | The Lancet. Infectious diseases | 2023 | 65 | 43 | |||
Increased Peripheral Venous Catheter Bloodstream Infections during COVID-19 Pandemic, Switzerland | Emerging infectious diseases | 2023 | 71 | 39 | |||
Are monoclonals the way forward to prevent or to treat ventilator-associated pneumonia in the intensive care unit ? | Expert opinion on biological therapy | 2023 | 37 | 0 | |||
Risk factors for acquisition of carbapenemase-producing versus non-carbapenemase-producing enterobacterales : a case-control study | Clinical microbiology and infection | 2023 | 70 | 0 | |||
Frequency of bloodstream infections caused by six key antibiotic-resistant pathogens for prioritization of research and discovery of new therapies in Europe : a systematic review | Clinical microbiology and infection | 2023 | 57 | 47 | |||
Synthesizing pathogen- and infection-specific estimates of the burden of antimicrobial resistance in Europe for health-technology assessment : gaps, heterogeneity, and bias | Clinical microbiology and infection | 2023 | 112 | 67 | |||
A systematic review on the excess health risk of antibiotic-resistant bloodstream infections for six key pathogens in Europe | Clinical microbiology and infection | 2023 | 57 | 44 | |||
Risk factors for infections caused by carbapenem-resistant Enterobacterales: an international matched case-control-control study (EURECA) | EClinicalMedicine | 2023 | 54 | 14 | |||
Risk factors for in-hospital mortality and secondary bacterial pneumonia among hospitalized adult patients with community-acquired influenza : a large retrospective cohort study | Antimicrobial resistance and infection control | 2023 | 46 | 16 | |||
Understanding the impact of antimicrobial resistance on outcomes of bloodstream infections in low- and middle-income countries | PLoS medicine | 2023 | 75 | 24 | |||
Mortality associated with third-generation cephalosporin resistance in Enterobacteriaceae bloodstream infections at one South African hospital | Journal of global antimicrobial resistance | 2022 | 50 | 13 | |||
Global burden of antimicrobial resistance: essential pieces of a global puzzle | Lancet | 2022 | 155 | 82 | |||
The first WHO global survey on infection prevention and control in health-care facilities | Lancet. Infectious diseases | 2022 | 141 | 242 | |||
Impact of environmental hygiene interventions on healthcare-associated infections and patient colonization: a systematic review | Antimicrobial resistance and infection control | 2022 | 140 | 178 | |||
Perpetual observational studies: new strategies to support efficient implementation of observational studies and randomized trials in infectious diseases | Clinical microbiology and infection | 2022 | 171 | 42 | |||
Lower risk of peripheral venous catheter-related bloodstream infection by hand insertion | Antimicrobial resistance and infection control | 2022 | 140 | 74 | |||
Implementation of hand hygiene in health-care facilities: results from the WHO Hand Hygiene Self-Assessment Framework global survey 2019 | Lancet. Infectious diseases | 2022 | 234 | 165 | |||
Results of an international pilot survey on healthcare environmental hygiene at the facility level | American journal of infection control | 2022 | 97 | 0 | |||
Methodological quality of studies evaluating the burden of drug-resistant infections in humans due to the WHO Global Antimicrobial Resistance Surveillance System target bacteria | Clinical microbiology and infection | 2021 | 126 | 85 | |||
Burden of Antimicrobial Resistance: Compared to What? | Epidemiologic reviews | 2021 | 38 | 28 | |||
Surveillance of resistance to new antibiotics in an era of limited treatment options | Frontiers in medicine | 2021 | 175 | 79 | |||
The effect of the COVID-19 pandemic on the epidemiology of positive blood cultures in Swiss intensive care units: a nationwide surveillance study | Critical care | 2021 | 186 | 46 | |||
Household acquisition and transmission of extended-spectrum β-lactamase (ESBL) -producing Enterobacteriaceae after hospital discharge of ESBL-positive index patients | Clinical Microbiology and Infection | 2021 | 231 | 275 | |||
Comparison of Routine Replacement With Clinically Indicated Replacement of Peripheral Intravenous Catheters | JAMA internal medicine | 2021 | 171 | 0 | |||
A one health framework to estimate the cost of antimicrobial resistance | Antimicrobial resistance and infection control | 2020 | 144 | 37 | |||
Industry incentives and antibiotic resistance: an introduction to the antibiotic susceptibility bonus | The Journal of Antibiotics | 2020 | 173 | 79 | |||
Association between treatment duration and mortality or relapse in adult patients with Staphylococcus aureus bacteraemia: a retrospective cohort study | Clinical Microbiology and Infection | 2020 | 219 | 1 | |||
Antibacterial efficacy of handrubbing for 15 versus 30 seconds: EN 1500-based randomized experimental study with different loads of Staphylococcus aureus and Escherichia coli | Clinical Microbiology and Infection | 2019 | 241 | 1 | |||
Impact of participation in a surgical site infection surveillance network: results from a large international cohort study | Journal of Hospital Infection | 2019 | 324 | 186 | |||
Optimizing the Design and Analysis of Clinical Trials for Antibacterials Against Multidrug-resistant Organisms: A White Paper From COMBACTE's STAT-Net | Clinical Infectious Diseases | 2018 | 292 | 165 | |||
Shining a light on ultraviolet-C disinfection: No golden promises for infection prevention | American Journal of Infection Control | 2018 | 334 | 0 | |||
Wiping Is Inferior to Rubbing: A Note of Caution for Hand Hygiene With Alcohol-Based Solutions | Infection Control and Hospital Epidemiology | 2018 | 321 | 0 | |||
Study protocol for a multicentre, cluster randomised, superiority trial evaluating the impact of computerised decision support, audit and feedback on antibiotic use: the COMPuterized Antibiotic Stewardship Study (COMPASS) | BMJ Open | 2018 | 520 | 224 | |||
Good epidemiological practice: a narrative review of appropriate scientific methods to evaluate the impact of antimicrobial stewardship interventions | Clinical Microbiology and Infection | 2017 | 531 | 0 | |||
The global hand-sanitizing relay: promoting hand hygiene through innovation | Journal of Hospital Infection | 2017 | 449 | 1 | |||
World Health Organization SAVE LIVES: Clean Your Hands global campaign-'Fight antibiotic resistance-it's in your hands' | Clinical Microbiology and Infection | 2017 | 440 | 1 | |||
Appropriate endpoints for evaluation of new antibiotic therapies for severe infections: a perspective from COMBACTE's STAT-Net | Intensive Care Medicine | 2017 | 460 | 235 | |||
Will 10 Million People Die a Year due to Antimicrobial Resistance by 2050? | PLOS Medicine | 2016 | 489 | 217 |